home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
IconOVir Bio to Present Preclinical Data on Lead Candidate ICVB-1042 at SITC 2022
IconOVir Bio to Present Preclinical Data on Lead Candidate ICVB-1042 at SITC 2022
Post navigation
Previous Post
Previous
Theseus Pharmaceuticals Nominates THE-349, a Fourth-Generation EGFR Inhibitor Development Candidate in Non-Small Cell Lung Cancer
Next Post
Next
IconOVir Bio Appoints Julia Maltzman, M.D., as Chief Medical Officer